Caribou Biosciences (CRBU) Non-cash Items (2020 - 2022)

Caribou Biosciences (CRBU) has 3 years of Non-cash Items data on file, last reported at $1.9 million in Q2 2022.

• Non-cash Items for Q2 2022 came in at $1.9 million, down 63.44% year-over-year; the trailing twelve-month figure through Jun 2022 was $1.9 million (down 63.44% YoY), and the FY2021 annual result was $1.3 million, down 81.3% from the prior year.
• Non-cash Items advanced to $1.9 million in Q2 2022 per CRBU's latest filing, from $1.6 million in the prior quarter.
• Over five years, Non-cash Items peaked at $50.1 million in Q4 2021 and troughed at $1.6 million in Q1 2022.
• A 3-year average of $11.4 million and a median of $5.2 million in 2021 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2021 and 2022: Non-cash Items surged 622.83% in 2021, then plunged 83.26% in 2022.
• A 3-year view of Non-cash Items shows it stood at $6.9 million in 2020, then surged by 622.83% to $50.1 million in 2021, then tumbled by 96.19% to $1.9 million in 2022.
• Business Quant data shows CRBU's Non-cash Items at $1.9 million in Q2 2022, $1.6 million in Q1 2022, and $50.1 million in Q4 2021.